GPER1 and triple-negative breast carcinoma: Additionally, in cell lines and in murine models of triple-negative breast cancer (TNBC), it has been observed that the activation of GPER by its G-1 agonist significantly inhibits the expression of IL-6 and VEGF-A and is also capable of suppressing the angiogenesis and progression of TNBC (83).